|
"liu c j"的相關文件
顯示項目 1111-1135 / 1268 (共51頁)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:33Z |
High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C
|
Hsu, C.-S.;Liu, C.-J.;Liu, C.-H.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu, C.-H.;Liu, C.-J.;Lin, C.-.;Liang, C.-C.;Hsu, S.-J.;Yang, S.-S.;Hsu, C.-S.;Tseng, T.-C.;Wang, C.-C.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:02:32Z |
Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: A randomised study
|
Liu, C.-H.;Liang, C.-C.;Lin, J.-W.;Chen, S.-I.;Tsai, H.-B.;Chang, C.-S.;Hung, P.-H.;Kao, J.-H.;Liu, C.-J.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:00:57Z |
A study on the efficacy of body-mind-spirit group therapy for patients with breast cancer
|
Liu, C.J.; Hsiung, P.C.; Chang, K.J.; Liu, Y.F.; Wang, K.C.; Hsiao, F.H.; Ng, S.M.; Chan, Cecilia L.W.;;Liu, Chun-Ju;Hsiung, Ping-Chuan;Chang, King-Jen;Liu, Yu-Fen;Wang, Kuo-Chang;Hsiao, Fei-Hsiu;Ng, Siu-Man;Chan, Cecilia Lw; PING-CHUAN HSIUNG; Liu, Chun-Ju; Liu, C.J.; Liu, C.J.; Hsiung, P.C.; Hsiung, Ping-Chuan; FEI-HSIU HSIAO; Hsiung, P.C.; Chang, King-Jen; Chang, K.J.; Liu, Y.F.; Liu, Y.F.; Liu, Yu-Fen; Wang, Kuo-Chang; Wang, K.C.; Hsiao, Fei-Hsiu; Hsiao, F.H.; Ng, S.M.; Ng, Siu-Man; Chan, Cecilia L.W.; Chan, Cecilia LW |
| 臺大學術典藏 |
2018-09-10T06:59:26Z |
Saddle-shaped dioxo-ruthenium(VI) and -osmium(VI) 2,3,5,7,8,10,12,13,15,17,18,20-dodecaphenylporphyrin (H2dpp) complexes. Synthesis, spectral characterisation and alkene oxidation by [RuVI(dpp)O2]
|
Liu, C.-J.;Yu, W.-Y.;Peng, S.-M.;Mak, T.C.W.;Che, C.-M.; Liu, C.-J.; Yu, W.-Y.; Peng, S.-M.; Mak, T.C.W.; Che, C.-M.; SHIE-MING PENG |
| 臺大學術典藏 |
2018-09-10T06:33:23Z |
Interspousal transmission of GB virus-C/Hepatitis G virus: A comparison with hepatitis C virus
|
Kao, J.-H.;Liu, C.-J.;Chen, P.-J.;Chen, W.;Hsiang, S.-C.;Lai, M.-Y.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:22Z |
Benign recurrent intrahepatic cholestasis
|
Liu, C.-J.;Kao, J.-H.;Chen, P.-J.;Lai, M.-Y.;Mao, T.-L.;Wang, T.-H.;Chen, D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:33:21Z |
Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7]
|
Tseng, T.-C.;Liu, C.-J.;Kao, J.-H.; Tseng, TC; CHUN-JEN LIU; Liu, CJ; JIA-HORNG KAO; Kao, JH. |
| 臺大學術典藏 |
2018-09-10T06:33:18Z |
Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients
|
Wang, C.-C.;Liu, C.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lai, My; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users
|
PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; Lai, MY; JIA-HORNG KAO; Chen, DS; Kao, JH.; Lin, C.-.;Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; Lin, CL; Liu, CJ |
| 臺大學術典藏 |
2018-09-10T06:33:03Z |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan
|
Tseng, T.-C.; Liu, C.-J.; Chen, P.-J.; Lai, M.-Y.; Lin, C.-L.; Kao, J.-K.; Chen, D.-S.; CHUN-JEN LIU; Tseng, TC; Liu, CJ; PEI-JER CHEN; DING-SHINN CHEN; Chen, PJ; JIA-HORNG KAO; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:33:02Z |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan
|
Shao, Yu-Yun; Liu, CJ; PEI-JER CHEN; Lai, MY; DING-SHINN CHEN; Lee, Yi-Hsuan; Hsieh, Min-Shu; JIA-HORNG KAO; Chen, PJ; Kao, JH; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Chen, DS.; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; 高祥豐; 邵幼雲; 鄭安理; 徐志宏; 呂理駿; 謝明書; 李宜軒; Hsu, CS; Hsu, C.-S.; Liu, C.-J.; Lai, M.-Y.; Chen, P.-J.; Kao, J.-H.; Chen, D.-S.; Lu, Li-Chun; CHUN-JEN LIU |
| 臺大學術典藏 |
2018-09-10T06:14:07Z |
Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer
|
Yang, M.-H.;Chang, S.-Y.;Chiou, S.-H.;Liu, C.-J.;Chi, C.-W.;Chen, P.-M.;Teng, S.-C.;Wu, K.-J.; SHU-CHUN TENG |
| 臺大學術典藏 |
2018-09-10T06:12:48Z |
Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma
|
Lin, C.-L.;Chen, J.-D.;Liu, C.-J.;Lee, P.-H.;Chen, P.-J.;Lai, M.-Y.;Kao, J.-H.;Chen, D.-S.; Lin, CL; PO-HUANG LEE; CHUN-JEN LIU; Chen, JD; DING-SHINN CHEN; Liu, CJ; JIA-HORNG KAO; Lee, PH; Chen, PJ; Lai, MY; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:00:49Z |
Pegylated interferons for the treatment of chronic hepatitis B.
|
Liu, C.J.;Kao, J.H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:48Z |
Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
|
Liu, C.-J.;Kao, J.-H.;Chen, P.-J.;Chen, T.-C.;Lin, F.-Y.;Lai, M.-Y.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study
|
Liu, C.-J.;Lai, M.-Y.;Chao, Y.-C.;Liao, L.-Y.;Yang, S.-S.;Hsiao, T.-J.;Hsieh, T.-Y.;Lin, C.-L.;Hu, J.-T.;Chen, C.-L.;Chen, P.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:47Z |
Mixed hepatitis B virus genotype infections: The more, the worse? [3]
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T06:00:46Z |
Clinical significance of occult hepatitis B virus infection cannot be overlooked [11]
|
Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; CHUN-JEN LIU; DING-SHINN CHEN; JIA-HORNG KAO |
顯示項目 1111-1135 / 1268 (共51頁)
<< < 40 41 42 43 44 45 46 47 48 49 > >>
每頁顯示[10|25|50]項目
|
